Cartalax (20mg)
Cartilage & Joint Support
Targets chondrocytes for healthy cartilage matrix production.
Research Applications & Benefits
- Cartilage cell targeting
- ECM production support
- Joint health research
What is Cartalax?
Targets chondrocytes for healthy cartilage matrix production.
Listed vial contents: 20mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
Short peptide bioregulator targeting chondrocytes (cartilage cells) and extracellular matrix production.
What are the research questions?
- Osteoarthritis support
- Cartilage degeneration
- Joint health maintenance
What does the published work describe?
Stimulation of extracellular matrix production by chondrocytes confirmed in vitro. Clinical reports of improved joint mobility and reduced pain.
What are the limits of this evidence?
The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.
Study references
- Khavinson VK. Peptide Bioregulators
These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is Cartalax handled in the lab?
Plan a Cartalax stock solution from the sequence, the listed molecular weight and, when reported for the same lot, net peptide content. Test-dissolve a small portion first, store the powder sealed, cold and dry, and split solutions into single-use aliquots. These are laboratory handling notes, not administration guidance.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- Cartalax
- CAS Number
- Molecular Weight
- HPLC Purity Specification
- ≥98%
- Category
- Bioregulators
- Starting Price
- $39.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Cartalax carries the purity specification shown above. Where a lot-specific CertikLabs Certificate of Analysis is available, the product page links its HPLC purity, LC-MS identity, and concentration results.
Frequently Asked Questions
Is Cartalax suitable for human consumption?
No. Cartalax is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.
What purity is Cartalax?
Cartalax carries a ≥98% HPLC purity specification. Check the product page for an available lot report.
How is Cartalax shipped and stored?
Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
